Description

BPC-157 + TB-500 Peptide Vials

BPC-157 + TB-500 blend is offered in 3 variants: 2mg BPC-157 + 2mg TB-500, totaling 4mg, 5mg BPC-157 + 5mg TB-500, totaling 10mg, and 10mg BPC-157 + 5mg TB-500, totaling 15mg.

Introduction

The BPC-157 + TB-500 Research Blend is a combination of two peptides, BPC-157 and TB-500, designed for research purposes only. These peptides have gained attention for their potential applications in various research areas.

Key Characteristics

BPC-157 (Body Protection Compound 157) is known for its wound-healing properties and tissue repair support. TB-500 (Thymosin Beta-4) is recognized for its potential role in promoting muscle growth and recovery.

Research Applications

This research blend is intended for scientific investigations exploring the properties and effects of BPC-157 and TB-500. Researchers may study their impact on wound healing, tissue repair, and muscle growth.

Research Benefits

Potential for Synergistic Effects

Researchers are interested in exploring whether the combination of BPC-157 and TB-500 may exhibit synergistic effects, enhancing the overall outcomes in certain research models.

BPC-157 and Wound-Healing Properties

Studies suggest that BPC-157 may contribute to the acceleration of wound healing and tissue repair processes, making it a subject of interest for wound care research.

TB-500 and Muscle Growth

TB-500 has been investigated for its potential role in promoting muscle growth and recovery. Research studies aim to elucidate the mechanisms behind these effects.

Summary

The BPC-157 + TB-500 Research Blend is formulated for scientific research purposes, focusing on wound healing, tissue repair, and muscle growth. Researchers are encouraged to explore the potential synergistic effects of these peptides, contributing to advancements in various fields.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Yuka Tokura, Yuki Nakayama, So-ichiro Fukada, Noriko Nara, Hiroshi Yamamoto, Ryoichi Matsuda, Takahiko Hara, Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblasts, The Journal of Biochemistry, Volume 149, Issue 1, January 2011, Pages 43–48. [Read More].
2. Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y, Zhang Y, Zhang W. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther. 2015 Apr 30;9:2485-99. doi: 10.2147/DDDT.S82030. PMID: 25995620; PMCID: PMC4425239. [Read More].